Paper - WANFANG MED ONLINE

You Position: Home > Paper

Angiogenesis related gene expression profiles of EA.hy926 cells induced by irbesartan: a possible novel therapeutic approach

( views:171, downloads:8 )

Author:: No author available

Journal Title:: Chinese Medical Journal

Issue:: 8

DOI:: 10.3760/cma.j.issn.0366-6999.2012.08.002

Key Word:: irbesartan;angiogenesis;angiotensin Ⅱ type 1 receptor blockers;receptor,angiotensin,type 1;receptor,angiotensin,type 2

Abstract： Background Angiogenesis occurs commonly in various physiological and pathological processes.Improving blood supply through promoting angiogenesis is a novel approach for treating ischemic diseases.Angiotensin Ⅱ type 1 receptor blockers (ARBs) dominate the management of hypertension,but evidence of their role in angiogenesis is contradictory.Here we explored the angiogenic effects of ARBs through characterizing gene expression of the human umbilical vein endothelial cell line EA.hy926 exposed to irbesartan.Methods The human umbilical vein endothelial cell line EA.hy926 was grown for 72 hours after treatment with different concentrations of irbesartan.The cell proliferative capacity was assessed by CCK8 assay at 24,48 and 72 hours.Gene expression levels in EA.hy926 cells responding to irbesartan were measured under optimal proliferation conditions by microarray analysis using Affymetrix U133 plus 2.0.The differential expression of genes involved in angiogenesis was identified through cluster analysis of the resulting microarray data.Quantitative RT-PCR and Western blotting analyses were used to validate differential gene expression related to the angiogenesis process.Results In the 10-4,10-5,10-6 mol/L treatment groups,cell proliferation studies revealed significantly increased proliferation in EA.hy926 cells after 24 hours of irbesartan treatment.However,after 48 and 72 hours of treatment with different concentrations of irbesartan,there was no significant difference in cell proliferation observed in any treatment group.We selected the group stimulated with irbersartan at a concentration of 10-6 mol/L for microarray experiments.Statistical analysis of the microarray data resulted in the identification of 56 gene transcripts whose expression patterns were significantly correlated,negatively or positively,with irbesartan treatment.Cluster analysis showed that these genes were involved in angiogenesis,extracellular stimulus,binding reactions and skeletal system morphogenesis.Of these 56 genes we identified seven genes (VEGF,KDR,PTGS2,PLXND1,ROBO4,LMO2,and COL5A1) involved in the angiogenesis process.qRT-PCR analysis of these genes confirmed the microarray results.Protein expression of three VEGF pathway genes (VEGF,KDR,and PTGS2) was further confirmed by Western blotting.Conclusions Our study showed that irbesartan may induce angiogenic effects in vascular endothelial cells.It suggested that the mechanism of angiogenic effects of ARBs might be attributed to the signaling cascade from angiotensin receptors in the VEGF pathway.It also provided evidence indicating that ARBs could be used as a novel therapeutic approach to treat chronic ischemic heart disease as well as anti-hypertensive agents.

Reference

[1]Paola Souza,Fabrizio Rizzardi,Gustavo Noleto,etc.Refractory remodeling of the microenvironment by abnormal type V collagen, apoptosis, and immune response in non-small cell lung cancer[J].2010,41(2).
[2]Matsuura K,Fukushima N,Honda A.Telmisartan induces proliferation of human endothelial progenitor cells via PPARgamma-dependent PI3K/Akt pathway.[J].2009,205(2).
[3]Fujita Y,Kamata Y,Kitasato H,etc.Reduced angiogenesis and delay in wound healing in angiotensin II type 1a receptor-deficient mice.[J].2009,63(9).
[4]M E, Pueyo,J B, Michel.Angiotensin II receptors in endothelial cells.[J].1997,29.
[5]Yamada Yoshihiro,Forster Alan,Pannell Richard,etc.The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target.[J].2002,21(9).
[6]Jung HJ,Kwon HJ,Suh YG,etc.Potent inhibition of in vivo angiogenesis and tumor growth by a novel cyclooxygenase-2 inhibitor, enoic acanthoic acid.[J].2007,98(12).
[7]David A. Walsh,De-En Hu,John Wharton,etc.Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma[J].1997,120(7).
[8]Murohara Toyoaki,Imaizumi Tsutomu,Shintani Satoshi,etc.Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis.[J].2002,109(5).
[9]Munk VC,Sanchez-de-Miguel L,Petrimpol M,etc.Angiotensin II induces angiogenesis in the hypoxic adult mouse heart in vitro through an AT2-B2 receptor pathway.[J].2007,49(5).
[10]M A Hull,J L Thomson,C J Hawkey.Expression of cyclooxygenase 1 and 2 by human gastric endothelial cells[J].1999,45(4).
[11]A, Nessa,S A, Latif,N I, Siddiqui,etc.Angiogenesis-a novel therapeutic approach for ischemic heart disease.[J].2009,18(2).
[12]Sasaki Y,Hori M,Gunawan ES,etc.Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.[J].1999,79(12).
[13]Van N Pham,Weinstein BM,Fishman MC,etc.Semaphorin-plexin signaling guides patterning of the developing vasculature.[J].2004,7(1).
[14]He Wang,Bronia Olszewski,Wendy Rosebury,etc.Impaired angiogenesis in SHR is associated with decreased KDR and MT1-MMP expression[J].2004,315(2).
[15]Kaji K,Tsujimoto T,Yoshiji H,etc.Synergistic inhibitory effect of gemcitabine and angiotensin type-1 receptor blocker, losartan, on murine pancreatic tumor growth via anti-angiogenic activities.[J].2009,22(2).
[16]Agnès Fichard,Jean-Philippe Kleman,Florence Ruggiero.Another look at collagen V and XI molecules[J].1995,14(7).
[17]Lu MM,Gitler AD,Epstein JA.PlexinD1 and Semaphorin Signaling Are Required in Endothelial Cells for Cardiovascular Development.[J].2004,7(1).
[18]Cao Z,Cooper ME,Rizkalla B,etc.Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors.[J].2003,14(12).
[19]Mazure NM,Brahimi Horn MC,Pouyssegur J.Protein kinases and the hypoxia-inducible factor-1, two switches in angiogenesis.[J].2003,9(7).
[20]McKenzie S,Scott DJ,Chapple KS,etc.Cyclooxygenase-2 expression and its association with increased angiogenesis in human abdominal aortic aneurysms.[J].2007,21(1).
[21]Carmeliet P.Mechanisms of angiogenesis and arteriogenesis.[J].2000,6(4).
[22]Olsson AK,Dimberg A,Kreuger J,etc.VEGF receptor signalling - in control of vascular function[J].2006,7(5).
[23]Yi KY,Seo EH,Kim YJ,etc.KR-31831, benzopyran derivative, inhibits VEGF-induced angiogenesis of HUVECs through suppressing KDR expression.[J].2008,32(6).
[24]Yokoo S,Nagai N,Ishida S,etc.Inhibition of corneal neovascularization by blocking the angiotensin II type 1 receptor.[J].2008,49(10).
[25]Munzenmaier D. H.,Greene A. S..Opposing Actions of Angiotensin II on Microvascular Growth and Arterial Blood Pressure[J].1996.
[26]Mateja, Legan,Bostjan, Luzar,Vera, Ferlan-Marolt,etc.Cyclooxygenase-2 expression determines neo-angiogenesis in gallbladder carcinomas.[J].2006,6(4).
[27]Unger T,Paul M,Steckelings UM,etc.The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.[J].1995,95(2).
[28]B, Schieffer,A, Wirger,M, Meybrunn,etc.Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.[J].1994,89.
[29]Cigdem Tokyol,, Fatma Aktepe,Fatma Hiisniye Dilek,etc.Expression of Cyclooxygenase-2 and MatrixMetalloproteinase-2 in Adenomyosis and Endometrial Polypsand its Correlation With Angiogenesis[J].2009,28(2).
[30]Ishii K,Fujiki M,Matsuda T,etc.Induced angiogenesis under cerebral ischemia by cyclooxygenase 2 and hypoxia-inducible factor naked DNA in a rat indirect-bypass model.[J].2006,409(2).
[31]Abdelsaid M,Johnson MH,Machado LS,etc.Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke.[J].2009,40(5).
[32]Andrade, S.P.,Cardoso, C.C.,Machado, R.D.P.,etc.Angiotensin-ll-lnduced Angiogenesis in Sponge Implants in Mice[J].1996,16(6).
[33]Diane H, Munzenmaier,Andrew S, Greene.Chronic angiotensin II AT1 receptor blockade increases cerebral cortical microvessel density.[J].2006,290(2).